BCAX
Bicara Therapeutics·NASDAQ
--
--(--)
--
--(--)
BCAX fundamentals
Bicara Therapeutics (BCAX) expects to report earnings on Mar 30, 2026, with estimated revenue of 0 (YoY --), and EPS at -0.6722 (YoY -72.36%).
Revenue estimate / YoY
0
--
EPS estimate / YoY
-0.6722
-72.36%
Report date
Mar 30, 2026
Earnings Call
8:30 AM on Mar 30, 2026
Meeting link.Earnings
EPS
Revenue
Revenue & Expenses
Key Indicators
Bicara Therapeutics (BCAX) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Bicara Therapeutics (BCAX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Bicara Therapeutics (BCAX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Bicara Therapeutics (BCAX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Bicara Therapeutics (BCAX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Bicara Therapeutics (BCAX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Bicara Therapeutics's revenue and profit?What guidance did Bicara Therapeutics's management provide for the next earnings period?What is Bicara Therapeutics's gross profit margin?What were the key takeaways from Bicara Therapeutics’s earnings call?What were the key takeaways from Bicara Therapeutics's earnings call?Did Bicara Therapeutics beat or miss consensus estimates last quarter?What is the market's earnings forecast for Bicara Therapeutics next quarter?What is the revenue and EPS growth rate for Bicara Therapeutics year over year?
